기본 정보
- 표준 SMILES
COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[N@@+](C)(CCCOC(=O)/C=C(\Cl)C(=O)OCCC[N@+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2- InChIKey
ZQLDXCSTJFLRPY-RWBXLJKRSA-N- 분자식
- C53H69ClN2O14+2
- 평균 분자량
- 993.6 g/mol
- 단동위원소 질량
- 992.44263541
개요
Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.
이름 및 식별자
- 우선 이름
- Gantacurium
- IUPAC
- 4-O-[3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 1-O-[3-[(1R,2S)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate
이름 및 동의어
GantacuriumGantacurium ionGantacurium cationN9VK9ZO25E758669-50-0DTXSID902267724-O-[3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 1-O-[3-[(1R,2S)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate4-O-(3-((1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propyl) 1-O-(3-((1R,2S)-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propyl) (Z)-2-chlorobut-2-enedioateRefChem:142620DTXCID20149263UNII-N9VK9ZO25ESCHEMBL2606283
이름 더 보기
CHEMBL1182997SCHEMBL29385798ZQLDXCSTJFLRPY-RWBXLJKRSA-NDB05710NS00073673Q27284755(1R,2S)-2-(3-{[(2Z)-2-Chloro-4-{3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydroisoquinolin-2-ium-2(1H)-yl]propoxy}-4-oxobut-2-enoyl]oxy}propyl)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium
데이터베이스 식별자
- CAS
758669-50-0- PubChem CID
- 10102486
- DTXSID
DTXSID90226772- ChEMBL
CHEMBL1182997- UNII
- N9VK9ZO25E
- Nikkaji
- J1.345.757C、J2.460.188I
물성
구조 계산 물성
- XLogP
- 8.3
- 극성 표면적
- 145 Ų
- 수소 결합 공여자 수
- 0
- 수소 결합 수용자 수
- 14
- 회전 가능 결합 수
- 25
- 무거운 원자 수
- 70
- 형식 전하
- 2
- 복잡도
- 1,640
실험 및 물리화학적 성질
DrugsPharmaceuticals -> Listed in ZINC15
화학 및 산업
약리 정보
Pharmacodynamics
Gantacurium chloride administered to anesthetized and ventilated healthy volunteers, caused dose dependent transient decrease in arterial blood pressure, mild histamine release at higher doses and no consistent changes in pulmonary compliance.
Biological Half-Life3.09±0.21 minutes
Metabolism/MetabolitesThe pharmacokinetic parameters are consistent with in situ rapid inactivation by plasma cysteine.
관련 반응
1건
연결된 노트
불러오는 중…